循环RNAs:瘤免疫逃避中的关键参与者
Mahla Sanati1, Soudeh Ghafouri-Fard2
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molecular and cellular biochemistry
|January 4, 2025
概括
循环RNAs (circRNAs) 是瘤免疫逃避的关键调节者. 这些非编码RNAs影响各种免疫细胞,提供新的治疗点来增强抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 非编码RNA研究研究
背景情况:
- 瘤生长通常是由对瘤抗原的免疫反应抑制的.
- 癌细胞使用复杂的机制,称为瘤免疫逃避,以克服这些抗瘤防御.
- 非编码RNA,特别是循环RNA (circRNA),已经成为调节瘤微环境和免疫细胞功能的关键参与者.
研究的目的:
- 审查circRNAs在瘤免疫逃避复杂过程中的多方面的作用.
- 要突出 circRNAs 如何调节参与抗瘤反应的关键免疫细胞的活动.
- 要强调理解circRNA功能在癌症免疫治疗中的治疗潜力.
主要方法:
- 关于circRNAs和瘤免疫逃避的最新研究的综合文献综述.
- 分析详细研究circRNA与免疫细胞 (如CD8+ T细胞,调节性T细胞和自然杀手细胞) 相互作用的研究.
- 对循环RNA介导的细胞因子产生和免疫细胞活性调节的研究结果的综合.
主要成果:
- 循环RNAs通过调节各种免疫细胞的功能,包括细胞毒性T淋巴细胞,调节性T细胞和自然杀手细胞,显著影响瘤免疫逃避.
- 已经确定了特定的circRNAs,它们可以促进或抑制抗瘤免疫反应.
- 这些非编码RNAs会影响瘤微环境中的免疫细胞贩运,激活和效应器功能.
结论:
- 循环RNAs是瘤免疫逃避景观的组成部分,影响抗瘤免疫的多个方面.
- 向circRNAs是开发新型癌症免疫疗法的有希望的策略.
- 对circRNA生物学的进一步研究将对利用它们的潜力来增强免疫系统对抗癌症的能力至关重要.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


